Directing a lineage‐tracing cassette to the KRT20 locus to track differentiated cells demonstrated that KRT20+ cells can reverse into LGR5+ cells with TIC capacity upon LGR5+‐cell ablation, thereby driving tumor re‐growth. This evidence concerns the gene KRT20 and neoplasm.